Showing 741 - 760 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant part) OR (significant positive)) decrease ))', query time: 0.51s Refine Results
  1. 741
  2. 742

    Fig 3 - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  3. 743

    S3 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  4. 744
  5. 745

    S5 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  6. 746

    Fig 5 - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  7. 747

    S1 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  8. 748
  9. 749

    S2 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  10. 750

    Fig 4 - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  11. 751
  12. 752
  13. 753

    S4 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  14. 754

    S6 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
  15. 755

    Minimal data set. by Xiaoxia Liu (294088)

    Published 2024
    “…Specifically, with a positive Soret coefficient, the growth rate of spherical crystals in a binary dilute alloy melt decreases as the coefficient increases, while the solute concentration near the interface increases. …”
  16. 756
  17. 757
  18. 758

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  19. 759

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  20. 760